EMA Authorised: Vimkunya (Chikungunya virus (CHIKV) virus-like particle (VLP) proteins (capsid protein (C) and envelope proteins E1 and E2) derived from CHIKV Senegal strain 37997 produced in human embryonic kidney cells by recombinant DNA technology, adsorbed on aluminium hydroxide, hydrated) — Bavarian Nordic A/S

View source ↗

Summary

The EMA authorised Vimkunya for chikungunya. Vimkunya is a chikungunya virus-like particle vaccine produced in human embryonic kidney cells by recombinant DNA t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chikungunya

Drugs mentioned

• Vimkunya

Snippet

Status: Authorised. Therapeutic area: Chikungunya virus. MAH: Bavarian Nordic A/S. Decision date: 28/02/2025